The long-term efficacy of nusinersen on respiratory functions in children with symptomatic spinal muscular atrophy type 1. [PDF]
Kiliç MA +9 more
europepmc +1 more source
A self-reported Brazilian registry of 5q-spinal muscular atrophy: data on natural history, genetic characteristics, and multidisciplinary care. [PDF]
Mendonça RH, Godoi JSA, Zanoteli E.
europepmc +1 more source
Diagnostic Journey of Korean Patients with Spinal Muscular Atrophy. [PDF]
Kim SH +6 more
europepmc +1 more source
Brazilian Portuguese version of the revised upper-limb module: cross-cultural adaptation and validation. [PDF]
Artilheiro MC +8 more
europepmc +1 more source
Clinical and Genetic Profiles of 5q- and Non-5q-Spinal Muscular Atrophy Diseases in Pediatric Patients. [PDF]
Nishio H +7 more
europepmc +1 more source
Respiratory outcomes of onasemnogene abeparvovec treatment for spinal muscular atrophy: national real-world cohort study. [PDF]
Lavie M +10 more
europepmc +1 more source
Spinal adhesive arachnoiditis in an adult patient with spinal muscular atrophy type 3 treated with intrathecal therapy. [PDF]
Ubysz J +3 more
europepmc +1 more source
Modern Surgery - Chapter 17. Tumors, or Morbid Growths [PDF]
Da Costa, John Chalmers
core +1 more source
Diabetes, Obesity and Metabolism, Volume 27, Issue 10, Page 6059-6067, October 2025.
Lauren M. Quinn +8 more
wiley +1 more source
Abnormal expression of myosin heavy chains in early postnatal stages of spinal muscular atrophy type I at single fibre level. [PDF]
Hedberg-Oldfors C +3 more
europepmc +1 more source

